Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Spesolimab in Pyoderma Gangrenosum: Complete Statistical AnalysisIndependent statistical analysis of Spesolimab in Pyoderma Gangrenosum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06092216).
- SPETIndependent statistical analysis of Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPGblockIndependent statistical analysis of Sphenopalatine Ganglion Blocks RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03666663).
- Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: Complete Statistical AnalysisIndependent statistical analysis of Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPI2Independent statistical analysis of Effect of MD1003 in Progressive Multiple Sclerosis (SPI2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02936037).
- SPICEIndependent statistical analysis of Curcumin and Function in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03085680).
- SPIDEPIndependent statistical analysis of Spinal Cord Stimulation for the Treatment of Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03433339).
- sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS: Complete Statistical AnalysisIndependent statistical analysis of sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02239562).
- SPIN-CHATIndependent statistical analysis of Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPIN-SSLED-FIndependent statistical analysis of The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Spinal Anesthesia Induced Hypotension During Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Spinal Anesthesia Induced Hypotension During Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00846651).
- Spinal Cord Stimulation to Augment Activity Based Therapy: Complete Statistical AnalysisIndependent statistical analysis of Spinal Cord Stimulation to Augment Activity Based Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03240601).
- Spinal Cord Stimulation to Restore Cough: Complete Statistical AnalysisIndependent statistical analysis of Spinal Cord Stimulation to Restore Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00116337).
- Spinal Cord Stimulation to Treat Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Spinal Cord Stimulation to Treat Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02828436).
- Spinal Excitation to Enhance Mobility: Complete Statistical AnalysisIndependent statistical analysis of Spinal Excitation to Enhance Mobility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03667573).
- Spinal Plasticity to Enhance Motor Retraining After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Spinal Plasticity to Enhance Motor Retraining After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645122).
- SPINETIndependent statistical analysis of Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPINSIndependent statistical analysis of Stress CMR Perfusion Imaging in the United States (SPINS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192891).
- Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): Complete Statistical AnalysisIndependent statistical analysis of Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-1Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPIRE-2Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-HRIndependent statistical analysis of Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events: primary endpoint results, effect estimate with confidence interval, sample-size…
- SPIRITIndependent statistical analysis of A Representational Intervention to Promote Preparation for End-of-life Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01259011).
- SPIRITIndependent statistical analysis of Antiarrhythmic Effects of Spironolactone in Patients With ICDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495712).
- SPIRITIndependent statistical analysis of Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244842).
- SPIRITIndependent statistical analysis of Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIRITIndependent statistical analysis of SP16 Inflammatory Response Inhibition Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04225533).
- SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System: Complete Statistical AnalysisIndependent statistical analysis of SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SPIRIT SVIndependent statistical analysis of SPIRIT Small Vessel Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00783796).
- SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): Complete Statistical AnalysisIndependent statistical analysis of SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): primary…
- SPIRITT – Second-Line Panitumumab Irinotecan Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418938).
- Spironolactone in Adult Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Spironolactone in Adult Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01069510).
- Spironolactone in Patients With Single Ventricle Heart: Complete Statistical AnalysisIndependent statistical analysis of Spironolactone in Patients With Single Ventricle Heart: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00211081).
- SPLASHIndependent statistical analysis of A Multi-Component Alcohol and Sex Risk Intervention for College Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05180539).
- SPLDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Split-DoseIndependent statistical analysis of Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SpO2 System Accuracy Testing With Different Sensors: Complete Statistical AnalysisIndependent statistical analysis of SpO2 System Accuracy Testing With Different Sensors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01613222).
- SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: Complete Statistical AnalysisIndependent statistical analysis of SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03124602).
- SPOTIndependent statistical analysis of UH3 Pragmatic Suicide Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02326883).
- SPOTFIRE Sore Throat (ST) Study: Complete Statistical AnalysisIndependent statistical analysis of SPOTFIRE Sore Throat (ST) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06713642).
- SpotlightIndependent statistical analysis of A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPOTLIGHT203Independent statistical analysis of BO-112 With Pembrolizumab in Unresectable Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570332).
- SPPIndependent statistical analysis of Supporting Parents Program: Intervention for Families in CPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01332851).
- SPP2Independent statistical analysis of Effect of Behavioral Nudges on Serious Illness Conversation Documentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04867850).
- SPREADIndependent statistical analysis of Sleep to Prevent Evolving Affecting Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02988375).
- SPREAD-NETIndependent statistical analysis of SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325531).
- Sprifermin (AS902330) in Cartilage Injury Repair (CIR): Complete Statistical AnalysisIndependent statistical analysis of Sprifermin (AS902330) in Cartilage Injury Repair (CIR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01066871).
- SPRINGIndependent statistical analysis of High-Risk Neuroblastoma Chemotherapy Without G-CSF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02786719).